Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

IDOR-1117-2520

Copy Product Info
😃Good
Catalog No. T86705Cas No. 2737274-49-4

IDOR-1117-2520 is a potent and selective CCR6 antagonist that effectively blocks CCL20-mediated calcium signaling and inhibits β-arrestin recruitment in human CCR6-expressing cells, thereby serving as a valuable pharmacological agent for investigating CCR6-driven immune cell migration and autoimmune disease mechanisms.

IDOR-1117-2520

IDOR-1117-2520

Copy Product Info
😃Good
Catalog No. T86705Cas No. 2737274-49-4
IDOR-1117-2520 is a potent and selective CCR6 antagonist that effectively blocks CCL20-mediated calcium signaling and inhibits β-arrestin recruitment in human CCR6-expressing cells, thereby serving as a valuable pharmacological agent for investigating CCR6-driven immune cell migration and autoimmune disease mechanisms.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$2,57010-14 weeks10-14 weeks
50 mg$3,36010-14 weeks10-14 weeks
100 mg$4,21010-14 weeks10-14 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
IDOR-1117-2520 is a potent and selective CCR6 antagonist that effectively blocks CCL20-mediated calcium signaling and inhibits β-arrestin recruitment in human CCR6-expressing cells, thereby serving as a valuable pharmacological agent for investigating CCR6-driven immune cell migration and autoimmune disease mechanisms.
In vivo
In the context of autoimmune disease models, IDOR-1117-2520 is evaluated for its ability to mitigate tissue inflammation. By preventing the infiltration of pathogenic Th17 cells into inflamed tissues, the compound aims to dampen the autoimmune response and reduce pathology. This mechanism is investigated in preclinical models of autoimmunity, such as skin inflammation (psoriasis) or intestinal inflammation (IBD) [1].
Chemical Properties
Molecular Weight436.55
FormulaC25H32N4O3
Cas No.2737274-49-4
Smiles[C@](O)(C1(C)CN(C)C1)(C=2C=C(C=NC2)C=3N=C(C(C)(C)O)ON3)C4=CC=C(C(C)C)C=C4
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy IDOR-1117-2520 | purchase IDOR-1117-2520 | IDOR-1117-2520 cost | order IDOR-1117-2520 | IDOR-1117-2520 chemical structure | IDOR-1117-2520 in vivo | IDOR-1117-2520 formula | IDOR-1117-2520 molecular weight